Paperonium

Blood vessels · Nat Med · 2012

The paper’s summary says high-cholesterol mice make less of a vessel-growth brake. Its data show more.

Its results and discussionmore: “increased”Its fish and cell testsmore particles, more VEGFR1same as normal miceThe summaryless: “downregulation”
Its results and discussionmore: “increased”Its fish and cell testsmore particles, more VEGFR1same as normal miceThe summaryless: “downregulation”

How VEGFR1, a vessel-growth brake, changes with more cholesterol-carrying particles

The paper says

VEGFR1 is a protein made by blood-vessel cells that slows vessel growth. The paper’s summary, the paragraph at the top, says mice bred to have high cholesterol (extra cholesterol-carrying particles in the blood) make less of it. Its word is “downregulation”, meaning a drop.

Its own data show

The paper’s results section says these same mice had “increased” VEGFR1 compared with normal mice, and its discussion says “elevated”. These are its only mouse experiments, so the summary cannot mean some other one. Its tests in fish and in human vessel cells agree: more of the particles brought more VEGFR1, fewer brought less.

VEGFR1 is a decoy: it grabs the signal telling vessels to grow, so more VEGFR1 means slower growth. The paper argues extra cholesterol-carrying particles hold growth back by raising VEGFR1. Read alone, the summary implies the reverse: high cholesterol eases the brake, freeing growth. The summary is what PubMed, the free medical search site, shows everyone. The data are unaffected.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1 · Nat Med (2012) · doi:10.1038/nm.2759